Abstract:Recently, the deep learning (DL) dimension of artificial intelligence has received much attention from biochemical researchers and thus has gradually become the key approach adopted in the area of biosensing applications. Studies have shown that the use of DL techniques for sensing can not only shorten the time of data analysis but also significantly increase the accuracy of data analysis and prediction, resulting in the performance improvement of biosensing systems in comparison to conventional methods. However, obtaining reliable equilibrium and rate constants of biomolecular interactions during the detection process remains difficult and time-consuming to date. In this study, we propose a transformed model based on the deep transfer learning and sequence-to-sequence autoencoder that can successfully transfer the SPR sensorgram to the protein-binding constants, that is, the association rate constant (ka) and dissociation rate constant (kd), which provide crucial information to understand the mechanisms of drug action and the functional structures of biomolecules. Experimentally, we first trained and tested the pre-trained model using the Langmuir model which generated ideal SPR sensorgrams and then we fine-tuned the pre-trained model through the augmented SPR sensorgrams which were synthesized by using the synthesized minority oversampling technique (SMOTE) through the moderate-scale experiment. Next, the fine-tuned model was inputted with a short experimental SPR sensorgram that only needs 110 s, and the sensorgram was directly transformed into a reconstructed ideal sensorgram. Finally, the binding kinetic constants, that is, ka and kd, as outputs, were obtained through fitting the reconstructed ideal sensorgram. The results showed that the prediction errors of ka and kd obtained by our model were less than 12 and 24%, respectively. Based on the convenience, accuracy, and reliability of the proposed DL approach, we believe our strategy significantly boosts the feasibility to monitor the binding affinity of antibodies online during production.

A time‐efficient computational binding affinity estimation protocol with utilization of limited experimental data: A case study for adenosine receptor

Results of Molecular Docking As Descriptors to Predict Human Serum Albumin Binding Affinity.

A Computational Workflow for Refining AF2 Models in Drug Design Using Kinetic and Thermodynamic Binding Calculations: A Case Study for the Unresolved Inactive human Adenosine A3 Receptor

A high quality, industrial data set for binding affinity prediction: performance comparison in different early drug discovery scenarios

Rapid and Reliable Binding Affinity Prediction of Bromodomain Inhibitors: A Computational Study

QuickBind: A Light-Weight And Interpretable Molecular Docking Model

Binding affinity in drug design: experimental and computational techniques

Recent advances in computational methods for studying ligand binding kinetics

Progress in molecular docking

SCORE: A New Empirical Method for Estimating the Binding Affinity of a Protein-Ligand Complex

Enhanced molecular dynamics sampling of drug target conformations

Computational Workflow for Refining AlphaFold Models in Drug Design Using Kinetic and Thermodynamic Binding Calculations: A Case Study for the Unresolved Inactive Human Adenosine A 3 Receptor

A Robust Induced Fit Docking Approach with the Combination of the Hybrid All-Atom/United-Atom/Coarse-Grained Model and Simulated Annealing

A selective method for optimizing ensemble docking-based experiments on an InhA Fully-Flexible receptor model

Accuracy and precision of binding free energy prediction for a tacrine related lead inhibitor of acetylcholinesterase with an arsenal of supercomputerized molecular modelling methods: a comparative study

Easy and Rapid Approach to Obtaining the Binding Affinity of Biomolecular Interactions Based on the Deep Learning Boost

Concurrent and Adaptive Extreme Scale Binding Free Energy Calculations

Binding Free Energy Calculation Based on the Fragment Molecular Orbital Method and Its Application in Designing Novel SHP-2 Allosteric Inhibitors

Understanding the impact of binding free energy and kinetics calculations in modern drug discovery

Further Development and Validation of Empirical Scoring Functions for Structure-Based Binding Affinity Prediction

Novel Scaffold Agonists of the α2A Adrenergic Receptor Identified via Ensemble-Based Strategy